Nagase (8012) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
20 Mar, 2026Executive summary
Profit in the trading business declined due to weak automobile-related business, despite strong Electronics & Energy and Life & Healthcare segments.
Prinova Group saw strong trading results from higher sales volume, with manufacturing recovering and Nutrition business improving efficiency.
Nagase Chemtex and Nagase Viita posted solid sales in semiconductors and food ingredients, respectively.
Net sales for the six months ended September 30, 2025, were ¥479,734 million, down 0.3% year-over-year.
Profit attributable to owners of the parent decreased 5.6% year-over-year to ¥15,089 million.
Financial highlights
FY2025 2Q sales: ¥4,797 hundred million (down ¥12 hundred million YoY); gross profit: ¥909 hundred million (up ¥29 hundred million YoY).
Operating income flat YoY at ¥210 hundred million; profit attributable to owners of parent down to ¥150 hundred million (down ¥8 hundred million YoY).
Gross profit margin rose to 19.0% from 18.3% YoY.
Manufacturing business profits rose by ¥3.3 billion, mainly from Prinova Group and Nagase Chemtex.
Gross profit increased 3.3% year-over-year to ¥90,913 million.
Outlook and guidance
Full-year forecast revised upward for net sales, gross profit, and ordinary profit, expecting record highs at each profit measurement.
FY2025 sales forecast: ¥9,640 hundred million (+2.0% YoY); gross profit: ¥1,830 hundred million (+5.5% YoY); operating income: ¥407 hundred million (+4.1% YoY).
Profit attributable to owners of parent forecast unchanged at ¥315 hundred million.
Full-year net sales forecast is ¥964,000 million, up 2.0% year-over-year.
Profit attributable to owners of the parent is forecast at ¥31,500 million, up 23.4% year-over-year.
Latest events from Nagase
- Record-high profits and margins in 2Q FY2024, led by strong semiconductor and materials demand.8012
Q2 202520 Mar 2026 - Record Q1 profit and margin growth driven by semiconductors, autos, and Functional Materials.8012
Q1 202520 Mar 2026 - Record-high profits and margins from semiconductors and electronics; guidance unchanged.8012
Q3 202520 Mar 2026 - Record profits and higher dividends, with further growth forecast for the next fiscal year.8012
Q4 202520 Mar 2026 - Record profits and a sharp net profit rise are forecast, led by semiconductors and food ingredients.8012
Q1 202620 Mar 2026 - Record-high profits and sales with strong growth in Life & Healthcare and higher dividends ahead.8012
Q3 202620 Mar 2026